The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Baldessarini, R. J.
* Articles by Centorrino, F.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Baldessarini, R. J.
* Articles by Centorrino, F.

Am J Psychiatry 1995; 152:1038-1044
Copyright © 1995 by American Psychiatric Association


REGULAR ARTICLES

Hospital use of antipsychotic agents in 1989 and 1993: stable dosing with decreased length of stay

RJ Baldessarini, JC Kando and F Centorrino
Department of Psychiatry, Harvard Medical School, Boston, MA, USA.

OBJECTIVE: This study evaluated recent and current use of antipsychotics by psychiatric inpatients. METHOD: Computer-based hospital pharmacy records identified prescriptions for antipsychotics in 1993. Medical records were reviewed to verify prescription and clinical data, and these were compared with similar data from 1989. RESULTS: In 1993, antipsychotics were prescribed for 299 (42%) of 709 hospitalized patients. Treatment usually started within 24 hours of admissions averaging 18 days. High-potency agents were used 2.4 times more frequently than low-potency drugs; 13% received clozapine. The mean chlorpromazine-equivalent daily dose, corrected for as-needed supplements, was 305 mg; peak doses were 32% higher. Doses of the most potent agents (fluphenazine and haloperidol) were only 22%-33% above the overall mean. Rarely were two neuroleptics given simultaneously, but cotreatment with an anticonvulsant (84% of patients, 92% of whom received valproate), a potent benzodiazepine (81%), lithium (70%), one CNS depressant (84%), or more (45%) was common. Doses averaged 20% higher for men, 42% lower at age > 50 years versus 20-30 years, and 53% greater for schizophrenia or schizoaffective disorder versus other conditions. Comparison with 1989 admissions (N = 50) averaging 73 days indicated few differences in use of neuroleptics or benzodiazepines but less frequent use of anticonvulsants and lithium. CONCLUSIONS: High- potency antipsychotic agents and clozapine were used most often in 1993; doses of high-potency agents were only slightly higher than doses of low-potency agents, but combinations with mood stabilizers were more common in 1993, when length of stay was one-fourth that in 1989.


This article has been cited by other articles:


Home page
Am. J. PsychiatryHome page
D. J. Safer, J. M. Zito, and S. dosReis
Concomitant Psychotropic Medication for Youths
Am J Psychiatry, March 1, 2003; 160(3): 438 - 449.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
F. Centorrino, M. Eakin, W.-M. Bahk, J. P. Kelleher, J. Goren, P. Salvatore, S. Egli, and R. J. Baldessarini
Inpatient Antipsychotic Drug Use in 1998, 1993, and 1989
Am J Psychiatry, November 1, 2002; 159(11): 1932 - 1935.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
C. A. Zarate Jr and J. Patel
Sudden Cardiac Death and Antipsychotic Drugs: Do We Know Enough?
Arch Gen Psychiatry, December 1, 2001; 58(12): 1168 - 1171.
[Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
J. COOKSON
Use of antipsychotic drugs and lithium in mania
The British Journal of Psychiatry, June 1, 2001; 178 (41): s148 - s156.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
G. Remington, C. M. Shammi, R. Sethna, and R. Lawrence
Antipsychotic Dosing Patterns for Schizophrenia in Three Treatment Settings
Psychiatr Serv, January 1, 2001; 52(1): 96 - 98.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1995 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org